270 related articles for article (PubMed ID: 19665786)
1. The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes.
Yang D; Pornpattananangkul D; Nakatsuji T; Chan M; Carson D; Huang CM; Zhang L
Biomaterials; 2009 Oct; 30(30):6035-40. PubMed ID: 19665786
[TBL] [Abstract][Full Text] [Related]
2. In vivo treatment of Propionibacterium acnes infection with liposomal lauric acids.
Pornpattananangkul D; Fu V; Thamphiwatana S; Zhang L; Chen M; Vecchio J; Gao W; Huang CM; Zhang L
Adv Healthc Mater; 2013 Oct; 2(10):1322-8. PubMed ID: 23495239
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.
Nakatsuji T; Kao MC; Fang JY; Zouboulis CC; Zhang L; Gallo RL; Huang CM
J Invest Dermatol; 2009 Oct; 129(10):2480-8. PubMed ID: 19387482
[TBL] [Abstract][Full Text] [Related]
4. Solid Lipid Nanoparticles Loaded with Retinoic Acid and Lauric Acid as an Alternative for Topical Treatment of Acne Vulgaris.
Silva EL; Carneiro G; De Araújo LA; Trindade Mde J; Yoshida MI; Oréfice RL; Farias Lde M; De Carvalho MA; Dos Santos SG; Goulart GA; Alves RJ; Ferreira LA
J Nanosci Nanotechnol; 2015 Jan; 15(1):792-9. PubMed ID: 26328443
[TBL] [Abstract][Full Text] [Related]
5. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
Han R; Blencke HM; Cheng H; Li C
Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
[TBL] [Abstract][Full Text] [Related]
6. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
[TBL] [Abstract][Full Text] [Related]
7. Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid.
Huang WC; Tsai TH; Chuang LT; Li YY; Zouboulis CC; Tsai PJ
J Dermatol Sci; 2014 Mar; 73(3):232-40. PubMed ID: 24284257
[TBL] [Abstract][Full Text] [Related]
8. In vitro anti-propionibacterium activity by curcumin containing vesicle system.
Liu CH; Huang HY
Chem Pharm Bull (Tokyo); 2013; 61(4):419-25. PubMed ID: 23546001
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial efficacy of granulysin-derived synthetic peptides in acne vulgaris.
Lim HS; Chun SM; Soung MG; Kim J; Kim SJ
Int J Dermatol; 2015 Jul; 54(7):853-62. PubMed ID: 25601314
[TBL] [Abstract][Full Text] [Related]
10. Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes.
McInturff JE; Wang SJ; Machleidt T; Lin TR; Oren A; Hertz CJ; Krutzik SR; Hart S; Zeh K; Anderson DH; Gallo RL; Modlin RL; Kim J
J Invest Dermatol; 2005 Aug; 125(2):256-63. PubMed ID: 16098035
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus paraplantarum THG-G10 as a potential anti-acne agent with anti-bacterial and anti-inflammatory activities.
Cha H; Kim SK; Kook M; Yi TH
Anaerobe; 2020 Aug; 64():102243. PubMed ID: 32712375
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice.
Ryu S; Han HM; Song PI; Armstrong CA; Park Y
PLoS One; 2015; 10(7):e0132619. PubMed ID: 26197393
[TBL] [Abstract][Full Text] [Related]
13. Design, preparation, and evaluation of liposomal gel formulations for treatment of acne: in vitro and in vivo studies.
Madan S; Nehate C; Barman TK; Rathore AS; Koul V
Drug Dev Ind Pharm; 2019 Mar; 45(3):395-404. PubMed ID: 30442066
[TBL] [Abstract][Full Text] [Related]
14. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a novel antiacne niosomal gel of rosmarinic acid.
Budhiraja A; Dhingra G
Drug Deliv; 2015; 22(6):723-30. PubMed ID: 24786487
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of the antimicrobial peptide BLP-7 against Propionibacterium acnes and its anti-inflammatory effect on acne vulgaris.
Wu Y; Qiang Y; Cao K; Zhang W; Zhang G
Toxicon; 2020 Sep; 184():109-115. PubMed ID: 32540219
[TBL] [Abstract][Full Text] [Related]
17. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression.
Nakatsuji T; Kao MC; Zhang L; Zouboulis CC; Gallo RL; Huang CM
J Invest Dermatol; 2010 Apr; 130(4):985-94. PubMed ID: 20032992
[TBL] [Abstract][Full Text] [Related]
18. Proteinase K/Retinoic Acid-Loaded Cationic Liposomes as Multifunctional Anti-Acne Therapy to Disorganize Biofilm and Regulate Keratinocyte Proliferation.
Tsai MJ; Lin CY; Trousil J; Sung CT; Lee MH; Fang JY; Yang SC
Int J Nanomedicine; 2023; 18():3879-3896. PubMed ID: 37483315
[TBL] [Abstract][Full Text] [Related]
19. A Polycation Antimicrobial Peptide Mimic without Resistance Buildup against Propionibacterium Acnes.
Nair SS; Zolotarskaya OY; Beckwith MJ; Ohman DE; Wynne KJ
Macromol Biosci; 2017 Sep; 17(9):. PubMed ID: 28605136
[TBL] [Abstract][Full Text] [Related]
20. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K
Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
